These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16917968)

  • 21. Effect of APOE genotype on lipid levels in patients with coronary heart disease during a 3-week inpatient rehabilitation program.
    Vossen CY; Hoffmann MM; Hahmann H; Wüsten B; Rothenbacher D; Brenner H
    Clin Pharmacol Ther; 2008 Aug; 84(2):222-7. PubMed ID: 18388879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
    Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
    Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternate-day dosing of atorvastatin: effects in treating type 2 diabetic patients with dyslipidaemia.
    Ferrer-García JC; Pérez-Silvestre J; Martínez-Mir I; Herrera-Ballester A
    Acta Diabetol; 2006 Nov; 43(3):75-8. PubMed ID: 17143784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [High-dose statin in ischemic stroke reduces the risk of recurrent stroke].
    Crisby M; Olsson AG
    Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3541-3. PubMed ID: 19133582
    [No Abstract]   [Full Text] [Related]  

  • 25. Ask the doctor. After a heart attack six years ago, I went on Lipitor (atorvastatin) because my doctor said it was proven to reduce the risk of a second heart attack in high-risk people like me. Three years ago, I switched to a generic (simvastatin) to save money. Now that Lipitor is going generic, should I switch back? And can I be assured that the generic version will be as effective as brand-name Lipitor at preventing a second heart attack?
    Lee T
    Harv Heart Lett; 2012 Jan; 22(5):8. PubMed ID: 22389921
    [No Abstract]   [Full Text] [Related]  

  • 26. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
    Zhao SP; Peng DQ; Yu BL; Huo Y;
    Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review.
    Schwertz DW; Badellino KO
    J Cardiovasc Nurs; 2008; 23(1):8-13. PubMed ID: 18158500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atorvastatin treatment and vaccination efficacy.
    Packard RR; Schlegel S; Senouf D; Burger F; Sigaud P; Perneger T; Siegrist CA; Mach F
    J Clin Pharmacol; 2007 Aug; 47(8):1022-7. PubMed ID: 17548534
    [No Abstract]   [Full Text] [Related]  

  • 29. Dose-related effect of statins on atrial fibrillation after cardiac surgery.
    Kourliouros A; De Souza A; Roberts N; Marciniak A; Tsiouris A; Valencia O; Camm J; Jahangiri M
    Ann Thorac Surg; 2008 May; 85(5):1515-20. PubMed ID: 18442529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins and antioxidant vitamins: should co-administration be avoided?
    Tousoulis D; Antoniades C; Stefanadis C
    J Am Coll Cardiol; 2006 Mar; 47(6):1237; author reply 1237-8. PubMed ID: 16545666
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of atorvastatin for achieving cholesterol targets after LDL-cholesterol based dose selection in patients with type 2 diabetes.
    Ferrer-García JC; Sanchez-Ballester E; Albalat-Galera R; Berzosa-Sanchez M; Herrera-Ballester A
    J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):183-8. PubMed ID: 18635754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of statins on glucose tolerance in patients with type 2 diabetes mellitus: subanalysis of the collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study).
    Yokote K; Saito Y;
    J Atheroscler Thromb; 2009 Jun; 16(3):297-8. PubMed ID: 19556714
    [No Abstract]   [Full Text] [Related]  

  • 33. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of hypercholesterolemia in patients with metabolic syndrome: how do different statins compare?
    Knopp RH; Paramsothy P
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):136-7. PubMed ID: 16932272
    [No Abstract]   [Full Text] [Related]  

  • 35. Towards a Paradigm Shift in Cholesterol Treatment. A Re-examination of the Cholesterol Issue in Japan.
    Hamazaki T; Okuyama H; Ogushi Y; Hama R
    Ann Nutr Metab; 2015; 66 Suppl 4():1-116. PubMed ID: 25925499
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
    Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular therapies and their role in diabetic eye disease.
    Denniston AK; Banerjee S; Gibson JM; Dodson PM
    Diabet Med; 2005 May; 22(5):665-6. PubMed ID: 15842530
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
    Goff DC; Gerstein HC; Ginsberg HN; Cushman WC; Margolis KL; Byington RP; Buse JB; Genuth S; Probstfield JL; Simons-Morton DG;
    Am J Cardiol; 2007 Jun; 99(12A):4i-20i. PubMed ID: 17599424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First head-to-head study comparing rosuvastatin and atorvastatin effects on the treatment of atherosclerosis.
    Cardiovasc J Afr; 2008; 19(1):60. PubMed ID: 18320096
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.
    Konduracka E; Galicka-Latala D; Cieslik G; Rostoff P; Fedak D; Sieradzki J; Naskalski J; Piwowarska W
    Diabetes Obes Metab; 2008 Sep; 10(9):719-25. PubMed ID: 17941871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.